Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review

Beta-3 adrenoceptor (B3AR) agonist which mediate detrusor relaxation has been tried as a new treatment modality for men with benign prostatic hyperplasia (BPH). However, it remains unclear whether the B3AR agonist has more clinical benefits and fewer adverse effects in men with BPH than in women. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Tae Wook, Kim, Su Jin, Kim, Myung Ha, Jung, Jae Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497732/
https://www.ncbi.nlm.nih.gov/pubmed/34610712
http://dx.doi.org/10.5213/inj.2142068.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497732/
https://www.ncbi.nlm.nih.gov/pubmed/34610712
http://dx.doi.org/10.5213/inj.2142068.034

Ejemplares similares